Unmet Need in Dry Eye Disease Market Leaves Room for Other Drugmakers to Step In

While there are a number of companies that have already developed different treatments for dry eye, including Novartis, Allergan, Sun Pharma and Bausch, the market is large enough to support more players. Global market share for dry eye was estimated at $5.4 billion in 2019 and is expected to grow by about 4% over the next 10 years.